
### [NCIT:C2900](http://purl.obolibrary.org/obo/NCIT_C2900)
**Label:** Bladder Disorder

**Subclasses:** [NCIT:C6416](http://purl.obolibrary.org/obo/NCIT_C6416) (Malignant Bladder Paraganglioma), [NCIT:C4912](http://purl.obolibrary.org/obo/NCIT_C4912) (Bladder Carcinoma), [NCIT:C4994](http://purl.obolibrary.org/obo/NCIT_C4994) (Stage II Bladder Squamous Cell Carcinoma), [NCIT:C7900](http://purl.obolibrary.org/obo/NCIT_C7900) (Stage IV Bladder Cancer AJCC v6), [NCIT:C4995](http://purl.obolibrary.org/obo/NCIT_C4995) (Recurrent Bladder Adenocarcinoma), [NCIT:C6414](http://purl.obolibrary.org/obo/NCIT_C6414) (Bladder Paraganglioma), [NCIT:C6178](http://purl.obolibrary.org/obo/NCIT_C6178) (Bladder Leiomyoma), [NCIT:C4032](http://purl.obolibrary.org/obo/NCIT_C4032) (Bladder Adenocarcinoma), [NCIT:C6177](http://purl.obolibrary.org/obo/NCIT_C6177) (Bladder Inflammatory Myofibroblastic Tumor), [NCIT:C7383](http://purl.obolibrary.org/obo/NCIT_C7383) (Bladder Papillary Urothelial Carcinoma), [NCIT:C4031](http://purl.obolibrary.org/obo/NCIT_C4031) (Bladder Squamous Cell Carcinoma), [NCIT:C39831](http://purl.obolibrary.org/obo/NCIT_C39831) (Non-Invasive Bladder Papillary Urothelial Neoplasm), [NCIT:C39833](http://purl.obolibrary.org/obo/NCIT_C39833) (Schistosoma Hematobium-Related Bladder Verrucous Carcinoma), [NCIT:C39832](http://purl.obolibrary.org/obo/NCIT_C39832) (Bladder Verrucous Carcinoma), [NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma), [NCIT:C27885](http://purl.obolibrary.org/obo/NCIT_C27885) (Infiltrating Bladder Urothelial Carcinoma), [NCIT:C27882](http://purl.obolibrary.org/obo/NCIT_C27882) (Bladder Low Grade Intraurothelial Neoplasia), [NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C9334](http://purl.obolibrary.org/obo/NCIT_C9334) (Malignant Bladder Neoplasm), [NCIT:C27768](http://purl.obolibrary.org/obo/NCIT_C27768) (Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma), [NCIT:C9461](http://purl.obolibrary.org/obo/NCIT_C9461) (Bladder Small Cell Neuroendocrine Carcinoma), [NCIT:C6191](http://purl.obolibrary.org/obo/NCIT_C6191) (Stage I Bladder Urothelial Carcinoma), [NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant), [NCIT:C89366](http://purl.obolibrary.org/obo/NCIT_C89366) (Stage IV Bladder Cancer), [NCIT:C90344](http://purl.obolibrary.org/obo/NCIT_C90344) (Bladder Carcinoma by AJCC v6 Stage), [NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements), [NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements), [NCIT:C2901](http://purl.obolibrary.org/obo/NCIT_C2901) (Bladder Neoplasm), [NCIT:C2900](http://purl.obolibrary.org/obo/NCIT_C2900) (Bladder Disorder), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), [NCIT:C39824](http://purl.obolibrary.org/obo/NCIT_C39824) (Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant), [NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant), [NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation), [NCIT:C27474](http://purl.obolibrary.org/obo/NCIT_C27474) (Superficial Bladder Carcinoma), [NCIT:C8898](http://purl.obolibrary.org/obo/NCIT_C8898) (Stage IV Bladder Adenocarcinoma), [NCIT:C8899](http://purl.obolibrary.org/obo/NCIT_C8899) (Stage I Bladder Cancer with Carcinoma In Situ), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C8896](http://purl.obolibrary.org/obo/NCIT_C8896) (Stage II Bladder Adenocarcinoma), [NCIT:C8897](http://purl.obolibrary.org/obo/NCIT_C8897) (Stage III Bladder Adenocarcinoma), [NCIT:C8894](http://purl.obolibrary.org/obo/NCIT_C8894) (Stage 0 Bladder Adenocarcinoma), [NCIT:C8895](http://purl.obolibrary.org/obo/NCIT_C8895) (Stage I Bladder Adenocarcinoma), [NCIT:C27634](http://purl.obolibrary.org/obo/NCIT_C27634) (Transplant-Related Bladder Urothelial Carcinoma), [NCIT:C9266](http://purl.obolibrary.org/obo/NCIT_C9266) (Recurrent Malignant Bladder Neoplasm), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39851](http://purl.obolibrary.org/obo/NCIT_C39851) (Bladder Urothelial Carcinoma), [NCIT:C126307](http://purl.obolibrary.org/obo/NCIT_C126307) (Recurrent Bladder Urothelial Carcinoma), [NCIT:C91202](http://purl.obolibrary.org/obo/NCIT_C91202) (Bladder Carcinoma by AJCC v7 Stage), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C39858](http://purl.obolibrary.org/obo/NCIT_C39858) (Bladder Urothelial Papilloma), [NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation), [NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation), [NCIT:C39857](http://purl.obolibrary.org/obo/NCIT_C39857) (Bladder Papillary Urothelial Neoplasm), [NCIT:C8939](http://purl.obolibrary.org/obo/NCIT_C8939) (Stage II Bladder Urothelial Carcinoma), [NCIT:C8904](http://purl.obolibrary.org/obo/NCIT_C8904) (Stage I Squamous Cell Carcinoma of the Bladder), [NCIT:C8905](http://purl.obolibrary.org/obo/NCIT_C8905) (Stage III Bladder Squamous Cell Carcinoma), [NCIT:C4669](http://purl.obolibrary.org/obo/NCIT_C4669) (Bladder Sarcoma), [NCIT:C8902](http://purl.obolibrary.org/obo/NCIT_C8902) (Recurrent Bladder Squamous Cell Carcinoma), [NCIT:C8903](http://purl.obolibrary.org/obo/NCIT_C8903) (Stage 0 Bladder Squamous Cell Carcinoma), [NCIT:C7898](http://purl.obolibrary.org/obo/NCIT_C7898) (Stage III Bladder Cancer), [NCIT:C7414](http://purl.obolibrary.org/obo/NCIT_C7414) (Bladder Villous Adenoma), [NCIT:C8901](http://purl.obolibrary.org/obo/NCIT_C8901) (Stage I Bladder Cancer without Carcinoma In Situ), [NCIT:C7897](http://purl.obolibrary.org/obo/NCIT_C7897) (Stage II Bladder Cancer), [NCIT:C7899](http://purl.obolibrary.org/obo/NCIT_C7899) (Recurrent Bladder Carcinoma), [NCIT:C8940](http://purl.obolibrary.org/obo/NCIT_C8940) (Stage III Bladder Urothelial Carcinoma), [NCIT:C8941](http://purl.obolibrary.org/obo/NCIT_C8941) (Stage IV Bladder Urothelial Carcinoma), [NCIT:C7896](http://purl.obolibrary.org/obo/NCIT_C7896) (Stage I Bladder Cancer), [NCIT:C7895](http://purl.obolibrary.org/obo/NCIT_C7895) (Stage 0 Bladder Cancer), [NCIT:C7650](http://purl.obolibrary.org/obo/NCIT_C7650) (Metastatic Malignant Neoplasm in the Bladder), [NCIT:C6164](http://purl.obolibrary.org/obo/NCIT_C6164) (Bladder Lymphoma), [NCIT:C37266](http://purl.obolibrary.org/obo/NCIT_C37266) (Bladder Flat Intraepithelial Lesion), [NCIT:C39842](http://purl.obolibrary.org/obo/NCIT_C39842) (Bladder Urachal Carcinoma), [NCIT:C3618](http://purl.obolibrary.org/obo/NCIT_C3618) (Benign Bladder Neoplasm), [NCIT:C39844](http://purl.obolibrary.org/obo/NCIT_C39844) (Bladder Urachal Urothelial Carcinoma), [NCIT:C118816](http://purl.obolibrary.org/obo/NCIT_C118816) (Childhood Bladder Carcinoma), [NCIT:C8906](http://purl.obolibrary.org/obo/NCIT_C8906) (Stage IV Bladder Squamous Cell Carcinoma), [NCIT:C39845](http://purl.obolibrary.org/obo/NCIT_C39845) (Bladder Urachal Squamous Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C2900](http://purl.obolibrary.org/obo/NCIT_C2900) (Bladder Disorder) 99.37%
- [NCIT:C2901](http://purl.obolibrary.org/obo/NCIT_C2901) (Bladder Neoplasm) 98.73%
- [NCIT:C9334](http://purl.obolibrary.org/obo/NCIT_C9334) (Malignant Bladder Neoplasm) 90.51%
- [NCIT:C4912](http://purl.obolibrary.org/obo/NCIT_C4912) (Bladder Carcinoma) 86.71%
- [NCIT:C3430](http://purl.obolibrary.org/obo/NCIT_C3430) (Urinary System Disorder) 75.21%
- [NCIT:C3431](http://purl.obolibrary.org/obo/NCIT_C3431) (Urinary System Neoplasm) 74.82%
- [NCIT:C2901](http://purl.obolibrary.org/obo/NCIT_C2901) (Bladder Neoplasm) and [NCIT:C39852](http://purl.obolibrary.org/obo/NCIT_C39852) (Urothelial Neoplasm) 68.99%
- [NCIT:C2900](http://purl.obolibrary.org/obo/NCIT_C2900) (Bladder Disorder) and [NCIT:C39852](http://purl.obolibrary.org/obo/NCIT_C39852) (Urothelial Neoplasm) 68.99%
- [NCIT:C91202](http://purl.obolibrary.org/obo/NCIT_C91202) (Bladder Carcinoma by AJCC v7 Stage) 66.46%
- [NCIT:C39851](http://purl.obolibrary.org/obo/NCIT_C39851) (Bladder Urothelial Carcinoma) 65.19%
- [NCIT:C4030](http://purl.obolibrary.org/obo/NCIT_C4030) (Urothelial Carcinoma) and [NCIT:C9334](http://purl.obolibrary.org/obo/NCIT_C9334) (Malignant Bladder Neoplasm) 65.19%
- [NCIT:C4030](http://purl.obolibrary.org/obo/NCIT_C4030) (Urothelial Carcinoma) and [NCIT:C4912](http://purl.obolibrary.org/obo/NCIT_C4912) (Bladder Carcinoma) 65.19%
- [NCIT:C39852](http://purl.obolibrary.org/obo/NCIT_C39852) (Urothelial Neoplasm) and [NCIT:C9334](http://purl.obolibrary.org/obo/NCIT_C9334) (Malignant Bladder Neoplasm) 65.19%
- [NCIT:C39852](http://purl.obolibrary.org/obo/NCIT_C39852) (Urothelial Neoplasm) and [NCIT:C4912](http://purl.obolibrary.org/obo/NCIT_C4912) (Bladder Carcinoma) 65.19%
- [NCIT:C2901](http://purl.obolibrary.org/obo/NCIT_C2901) (Bladder Neoplasm) and [NCIT:C4030](http://purl.obolibrary.org/obo/NCIT_C4030) (Urothelial Carcinoma) 65.19%


